Verrica Pharmaceuticals Inc. (VRCA)
Largest Insider Buys in Sector
VRCA Stock Price History Chart
VRCA Stock Performance
About Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.
Insider Activity of Verrica Pharmaceuticals Inc.
Over the last 12 months, insiders at Verrica Pharmaceuticals Inc. have bought $21.65M and sold $1.08M worth of Verrica Pharmaceuticals Inc. stock.
On average, over the past 5 years, insiders at Verrica Pharmaceuticals Inc. have bought $12.4M and sold $1.11M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Manning Paul B () — $102M. Stalfort John A III (director) — $3M. Rieger Jayson (CEO and President) — $249,999.
The last purchase of 22,921,348 shares for transaction amount of $20.4M was made by Manning Paul B () on 2024‑11‑22.
List of Insider Buy and Sell Transactions, Verrica Pharmaceuticals Inc.
| 2024-11-22 | 22.92M 45.1241% | $0.89 | $20.4M | -24.59% | ||||
| 2024-11-22 | director | 1.12M 2.212% | $0.89 | $1,000,000 | -24.59% | |||
| 2024-11-22 | CEO and President | 280,898 0.553% | $0.89 | $249,999 | -24.59% | |||
| 2024-08-27 | Sale | PRESIDENT AND CEO | 9,021 0.0211% | $2.46 | $22,192 | -47.97% | ||
| 2024-08-27 | Sale | CHIEF LEGAL OFFICER | 9,530 0.0223% | $2.46 | $23,444 | -47.97% | ||
| 2024-08-27 | Sale | Chief Medical Officer | 3,601 0.0084% | $2.46 | $8,858 | -47.97% | ||
| 2024-08-27 | Sale | CHIEF COMMERCIAL OFFICER | 8,993 0.0211% | $2.46 | $22,123 | -47.97% | ||
| 2024-08-27 | Sale | CHIEF FINANCIAL OFFICER | 7,899 0.0185% | $2.46 | $19,432 | -47.97% | ||
| 2024-08-26 | Sale | PRESIDENT AND CEO | 24,979 0.0606% | $2.66 | $66,444 | -50.19% | ||
| 2024-08-26 | Sale | CHIEF LEGAL OFFICER | 26,183 0.0635% | $2.66 | $69,647 | -50.19% | ||
| 2024-08-26 | Sale | Chief Medical Officer | 9,888 0.024% | $2.66 | $26,302 | -50.19% | ||
| 2024-08-26 | Sale | CHIEF COMMERCIAL OFFICER | 24,709 0.0599% | $2.66 | $65,726 | -50.19% | ||
| 2024-08-26 | Sale | CHIEF FINANCIAL OFFICER | 21,820 0.0529% | $2.66 | $58,041 | -50.19% | ||
| 2024-07-23 | Sale | PRESIDENT AND CEO | 154 0.0003% | $6.98 | $1,075 | +1.86% | ||
| 2024-07-23 | Sale | CHIEF LEGAL OFFICER | 91 0.0002% | $6.98 | $635 | +1.86% | ||
| 2024-07-23 | Sale | Chief Medical Officer | 86 0.0002% | $6.98 | $600 | +1.86% | ||
| 2024-07-23 | Sale | CHIEF COMMERCIAL OFFICER | 115 0.0003% | $6.98 | $803 | +1.86% | ||
| 2024-07-22 | Sale | PRESIDENT AND CEO | 32,469 0.0765% | $7.06 | $229,231 | -80.24% | ||
| 2024-07-22 | Sale | CHIEF LEGAL OFFICER | 21,649 0.051% | $7.06 | $152,842 | -80.24% | ||
| 2024-07-22 | Sale | Chief Medical Officer | 18,421 0.0434% | $7.06 | $130,052 | -80.24% |
Insider Historical Profitability
| Manning Paul B | 26278094 29.0158% | $0.66 | 19 | 0 | +7.38% | |
| Stalfort John A III | director | 1823800 2.0138% | $0.66 | 5 | 0 | +51.41% |
| Rieger Jayson | CEO and President | 832826 0.9196% | $0.66 | 1 | 0 | |
| White Ted | PRESIDENT AND CEO | 215967 0.2385% | $0.66 | 7 | 7 | +0.47% |
| Hayes Christopher G. | CHIEF LEGAL OFFICER | 105773 0.1168% | $0.66 | 3 | 7 | +53.25% |
| Goldenberg Gary | Chief Medical Officer | 94261 0.1041% | $0.66 | 1 | 7 | +61.6% |
| Bonaccorso Joe | CHIEF COMMERCIAL OFFICER | 73114 0.0807% | $0.66 | 1 | 7 | <0.0001% |
| Kohler Terry | CHIEF FINANCIAL OFFICER | 44697 0.0494% | $0.66 | 0 | 4 | |
| PERCEPTIVE ADVISORS LLC | 10 percent owner | 7099182 7.8388% | $0.66 | 10 | 0 | <0.0001% |
| EDELMAN JOSEPH | 5038983 5.564% | $0.66 | 1 | 0 | +61.6% | |
| Davidson Matt | 10 percent owner | 2556179 2.8225% | $0.66 | 0 | 160 | |
| DAVIS A BRIAN | Chief Financial Officer | 12900 0.0142% | $0.66 | 2 | 0 | +77.03% |
| Ballaron Craig | director | 10000 0.011% | $0.66 | 2 | 0 | +25.32% |
| Palczuk Linda | Chief Operating Officer | 8500 0.0094% | $0.66 | 3 | 0 | <0.0001% |
| Degnan Chris | Chief Financial Officer | 3000 0.0033% | $0.66 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| Perceptive Advisors | $42.03M | 16.74 | 7.1M | 0% | +$0 | 0.03 | |
| Avoro Capital Advisors Llc | $23.68M | 9.43 | 4M | 0% | +$0 | 0.28 | |
| Fidelity Investments | $8.93M | 3.56 | 1.51M | +0.01% | +$1,101.12 | <0.01 | |
| The Vanguard Group | $7.51M | 2.99 | 1.27M | +0.6% | +$45,045.28 | <0.0001 | |
| BlackRock | $6.6M | 2.63 | 1.11M | -1.91% | -$128,363.38 | <0.0001 | |
| Geode Capital Management | $2.66M | 1.06 | 449,309 | +4.57% | +$116,234.88 | <0.0001 | |
| State Street | $2.44M | 0.97 | 412,603 | +6% | +$138,149.13 | <0.0001 | |
| Northern Trust | $1.18M | 0.47 | 198,722 | -0.08% | -$941.28 | <0.0001 | |
| Deutsche Bank | $1.09M | 0.43 | 183,574 | +114.58% | +$580,290.20 | <0.0001 | |
| Bml Capital Management Llc | $1.07M | 0.42 | 180,000 | 0% | +$0 | 0.82 | |
| SteelPeak Wealth | $816,582.00 | 0.33 | 137,936 | +0.44% | +$3,552.00 | 0.04 | |
| Morgan Stanley | $794,558.00 | 0.32 | 134,216 | +20.58% | +$135,633.00 | <0.0001 | |
| Miracle Mile Advisors | $699,868.00 | 0.28 | 118,221 | 0% | +$0 | 0.01 | |
| Wellington Management Company | $606,119.00 | 0.24 | 102,385 | New | +$606,119.00 | <0.0001 | |
| Nuveen | $562,589.00 | 0.22 | 95,032 | 0% | +$0 | <0.0001 | |
| Bridgeway Capital Management | $486,624.00 | 0.19 | 82,200 | -23% | -$145,336.00 | 0.01 | |
| Kornitzer Capital Management Inc Ks | $439,566.00 | 0.18 | 74,251 | 0% | +$0 | 0.01 | |
| Charles Schwab | $327,708.00 | 0.13 | 55,356 | 0% | +$0 | <0.0001 | |
| BNY Mellon | $321,379.00 | 0.13 | 54,287 | -2.59% | -$8,536.64 | <0.0001 | |
| Kovitz | $296,740.00 | 0.12 | 50,125 | 0% | +$0 | <0.01 | |
| SPC Financial, Inc. | $177,600.00 | 0.07 | 30,000 | 0% | +$0 | 0.02 | |
| BECK MACK + OLIVER | $177,600.00 | 0.07 | 30,000 | 0% | +$0 | <0.01 | |
| Mml Investors Services Llc | $162,000.00 | 0.06 | 27,312 | -81.49% | -$713,186.73 | <0.01 | |
| Bank of America | $159,656.00 | 0.06 | 26,969 | -26.48% | -$57,494.87 | <0.0001 | |
| J. Goldman & Company | $159,840.00 | 0.06 | 27,000 | -75% | -$479,520.00 | 0.01 | |
| Two Sigma | $148,527.00 | 0.06 | 25,089 | New | +$148,527.00 | <0.0001 | |
| UBS | $132,205.00 | 0.05 | 22,332 | -8.05% | -$11,573.56 | <0.0001 | |
| RhumbLine Advisers | $130,688.00 | 0.05 | 22,077 | -1.39% | -$1,841.01 | <0.0001 | |
| Stifel | $121,360.00 | 0.05 | 20,500 | 0% | +$0 | <0.0001 | |
| Goldman Sachs | $115,766.00 | 0.05 | 19,555 | New | +$115,766.00 | <0.0001 | |
| Creative Planning | $112,587.00 | 0.05 | 19,018 | 0% | +$0 | <0.0001 | |
| Mariner Llc | $103,517.00 | 0.04 | 17,486 | New | +$103,517.00 | <0.0001 | |
| Barclays | $86,000.00 | 0.03 | 14,594 | -49.04% | -$82,770.73 | <0.0001 | |
| Dimensional Fund Advisors | $68,992.00 | 0.03 | 11,654 | 0% | +$0 | <0.0001 | |
| Cambridge Investment Research Advisors Inc | $68,000.00 | 0.03 | 11,500 | New | +$68,000.00 | <0.0001 | |
| BB&T | $62,426.00 | 0.03 | 10,545 | 0% | +$0 | <0.0001 | |
| American International Group | $60,905.00 | 0.02 | 10,288 | -0.86% | -$526.88 | <0.0001 | |
| New York State Common Retirement Fund | $58,000.00 | 0.02 | 9,769 | +7.56% | +$4,078.82 | <0.0001 | |
| JPMorgan Chase | $51,794.00 | 0.02 | 8,749 | -35.64% | -$28,682.36 | <0.0001 | |
| Wells Fargo | $45,809.00 | 0.02 | 7,738 | -21.86% | -$12,816.81 | <0.0001 | |
| Spire Wealth Management | $33,448.00 | 0.01 | 5,650 | 0% | +$0 | <0.01 | |
| Citigroup | $22,525.00 | 0.01 | 3,805 | +27.68% | +$4,883.87 | <0.0001 | |
| Salomon & Ludwin | $17,168.00 | 0.01 | 2,900 | 0% | +$0 | <0.01 | |
| Legal & General | $14,954.00 | 0.01 | 2,526 | 0% | +$0 | <0.0001 | |
| Royal Bank of Canada | $15,000.00 | 0.01 | 2,481 | -71.69% | -$37,974.61 | <0.0001 | |
| CalSTRS | $12,426.00 | 0.01 | 2,099 | -38.91% | -$7,914.99 | <0.0001 | |
| Simplex Trading Llc | $13,000.00 | 0.01 | 2,289 | -49.39% | -$12,687.64 | <0.0001 | |
| Ameritas Investment Partners Inc | $10,206.00 | <0.01 | 1,724 | 0% | +$0 | <0.0001 | |
| Tower Research Capital | $9,040.00 | <0.01 | 1,527 | -25.29% | -$3,060.69 | <0.0001 | |
| Amalgamated Bank | $4,000.00 | <0.01 | 704 | -76.18% | -$12,795.45 | <0.0001 |